Lara Meisner - 09 Mar 2023 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role: General Counsel and Secretary
Signature: /s/ Kristian Humer, Attorney-in-Fact for Lara Meisner
Issuer symbol: VRDN
Transactions as of: 09 Mar 2023
Transactions value $: -$871,257
Form type: 4
Date filed: 10 Mar 2023, 15:05
Previous filing: 10 Feb 2023
Next filing: 06 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VRDN	Common Stock	Sale	-$871K	-30K	-100%	$29.07	0	09 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.23 to $29.81. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Content

This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $28.23 to $29.81. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.